Pharvaris Announces $66 Million Series B Financing to Advance the Clinical Development of an Oral Therapy for Hereditary Angioedema

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2N9mYWG
via IFTTT